Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gordon

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Investigational New Drugs|May 31, 2020
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinomaBradley A McGregor, Michael Gordon, Ronan Flippot, et al.
Surgical Neurology International|December 18, 2025
First reported case of an intradural otic polyp arising from a cranial nerve with concomitant middle ear cholesteatomaKantha Siddhanth Gujjari, Frederick P Mariajoseph, Ameen Farsakh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomasAndrew J Wagner, Rashmi Chugh, Lee S Rosen, et al.
Royal Society Open Science|September 30, 2022
Forecasting the publication and citation outcomes of COVID-19 preprintsMichael Gordon, Michael Bishop, Yiling Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I trial of imexon in patients with advanced malignancyTomislav Dragovich, Michael Gordon, David Mendelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinomaScot Ebbinghaus, Maha Hussain, Nizar Tannir, et al.
Royal Society Open Science|September 3, 2020
Are replication rates the same across academic fields? Community forecasts from the DARPA SCORE programmeMichael Gordon, Domenico Viganola, Michael Bishop, et al.
Drug and Alcohol Dependence|November 5, 2025
Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine programAnnabelle M Belcher, Hannah Smith, Christopher Welsh, et al.
ACS Central Science|March 2, 2022
Depinning of Multiphase Fluid Using Light and Photo-Responsive SurfactantsLei Zhao, Serena Seshadri, Xichen Liang, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumorsMonica Mita, Michael Gordon, Lee Rosen, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Investigational New Drugs|May 31, 2020
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinomaBradley A McGregor, Michael Gordon, Ronan Flippot, et al.
Surgical Neurology International|December 18, 2025
First reported case of an intradural otic polyp arising from a cranial nerve with concomitant middle ear cholesteatomaKantha Siddhanth Gujjari, Frederick P Mariajoseph, Ameen Farsakh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
A phase I study of the HSP90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft-tissue sarcomasAndrew J Wagner, Rashmi Chugh, Lee S Rosen, et al.
Royal Society Open Science|September 30, 2022
Forecasting the publication and citation outcomes of COVID-19 preprintsMichael Gordon, Michael Bishop, Yiling Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I trial of imexon in patients with advanced malignancyTomislav Dragovich, Michael Gordon, David Mendelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinomaScot Ebbinghaus, Maha Hussain, Nizar Tannir, et al.
Royal Society Open Science|September 3, 2020
Are replication rates the same across academic fields? Community forecasts from the DARPA SCORE programmeMichael Gordon, Domenico Viganola, Michael Bishop, et al.
Drug and Alcohol Dependence|November 5, 2025
Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine programAnnabelle M Belcher, Hannah Smith, Christopher Welsh, et al.
ACS Central Science|March 2, 2022
Depinning of Multiphase Fluid Using Light and Photo-Responsive SurfactantsLei Zhao, Serena Seshadri, Xichen Liang, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumorsMonica Mita, Michael Gordon, Lee Rosen, et al.
Pageof 20